Quartic.ai, a manufacturing AI and IIoT platform supplier, and Bright Path Laboratories, a provider of continuous flow reactor technologies, have signed an agreement to develop an AI-powered continuous manufacturing platform for active pharmaceutical ingredients...
Media
Bright Path Laboratories Develops New Way to Produce Active Pharmaceutical Ingredients
Bright Path Laboratories, Inc. (privately held) 3-year-old startup contract manufacturer – with offices in both Charlotte and Santa Fe, N.M. – recently got a strong show of support from The U.S. Food and Drug Administration for its patented spinning-tube-in-tube (STT)...
Contract Pharma Reports, Bright Path Labs Accepted into FDA’s Emerging Technology Program
Bright Path Laboratories, Inc. (BPL), a provider of continuous flow reactor technology, was accepted into the FDA's Emerging Technology Program, paving the way for the company to provide its low-cost and scalable technology to the domestic API manufacturing sector....
Medicine-for-All Institute (VCU) selects BPP as First Commercial Manufacturing Partner
RICHMOND, VA Bright Path Pharmaceuticals, LLC (privately held) today announced that the Medicines for All Institute, a joint venture between Virginia Commonwealth University and the Gates Foundation, has selected BPP as its' first commercial innovation manufacturing...
ChemWerth’s Dr. Xiping Su joins BPP’s Board
RICHMOND, VA Bright Path Pharmaceuticals, LLC (privately held), today announced that ChemWerth's Chief Scientific Officer, Dr. Xiping Su, has joined the Board of the company following their investment in BPP. Xiping Su, Ph.D., is organic chemistry and ChemWerth’s head...
Todd N. Smith joins BPP Board
CHARLOTTE, NC Bright Path Pharmaceuticals, LLC (privately held) today announced that Todd N. Smith, Chairman and CEO of Novum Pharma will join the Board. Mr. Smith has twenty-five years of pharmaceutical, medical device and biotechnology general management experience...